CN116676315A - Cephalosporium camellia gene CcUOX and application thereof - Google Patents
Cephalosporium camellia gene CcUOX and application thereof Download PDFInfo
- Publication number
- CN116676315A CN116676315A CN202211457590.1A CN202211457590A CN116676315A CN 116676315 A CN116676315 A CN 116676315A CN 202211457590 A CN202211457590 A CN 202211457590A CN 116676315 A CN116676315 A CN 116676315A
- Authority
- CN
- China
- Prior art keywords
- gene
- ccuox
- camellia
- protein
- pathogenicity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 90
- 240000001548 Camellia japonica Species 0.000 title claims description 18
- 235000018597 common camellia Nutrition 0.000 title claims description 16
- 241001619326 Cephalosporium Species 0.000 title description 3
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 40
- 241001478662 Colletotrichum camelliae Species 0.000 claims abstract description 21
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960001948 caffeine Drugs 0.000 claims abstract description 20
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 19
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims abstract description 16
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229940116269 uric acid Drugs 0.000 claims abstract description 16
- 230000007918 pathogenicity Effects 0.000 claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 9
- 239000002773 nucleotide Substances 0.000 claims abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 6
- 241000196324 Embryophyta Species 0.000 claims description 20
- 230000014509 gene expression Effects 0.000 claims description 16
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 11
- 239000013598 vector Substances 0.000 claims description 8
- 235000006468 Thea sinensis Nutrition 0.000 claims description 6
- 230000005764 inhibitory process Effects 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 5
- 241000589876 Campylobacter Species 0.000 claims description 4
- 208000035240 Disease Resistance Diseases 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 244000052616 bacterial pathogen Species 0.000 claims description 2
- 230000033228 biological regulation Effects 0.000 claims 2
- 241000209507 Camellia Species 0.000 claims 1
- 244000052707 Camellia sinensis Species 0.000 claims 1
- 241001157813 Cercospora Species 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 abstract description 15
- 240000003553 Leptospermum scoparium Species 0.000 abstract description 15
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 15
- 230000015556 catabolic process Effects 0.000 abstract description 5
- 238000006731 degradation reaction Methods 0.000 abstract description 5
- 238000012216 screening Methods 0.000 abstract description 5
- 238000010353 genetic engineering Methods 0.000 abstract description 4
- 150000001413 amino acids Chemical class 0.000 abstract description 3
- 239000002299 complementary DNA Substances 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 238000013461 design Methods 0.000 abstract description 2
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 239000002699 waste material Substances 0.000 abstract description 2
- 230000000593 degrading effect Effects 0.000 abstract 1
- 101150006608 ox gene Proteins 0.000 abstract 1
- 230000004144 purine metabolism Effects 0.000 abstract 1
- 241000233866 Fungi Species 0.000 description 11
- 244000269722 Thea sinensis Species 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 241000193738 Bacillus anthracis Species 0.000 description 4
- 230000000443 biocontrol Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000012224 gene deletion Methods 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 241000222199 Colletotrichum Species 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 238000010835 comparative analysis Methods 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 239000002068 microbial inoculum Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical group O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 101100184662 Caenorhabditis elegans mogs-1 gene Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 244000000004 fungal plant pathogen Species 0.000 description 2
- 239000010921 garden waste Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000006467 Camellia japonica Nutrition 0.000 description 1
- 241000526900 Camellia oleifera Species 0.000 description 1
- 240000006833 Camellia sasanqua Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000244160 Echinococcus Species 0.000 description 1
- 101000800568 Hemicentrotus pulcherrimus T-box transcription factor T homolog Proteins 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241001085826 Sporotrichum Species 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- -1 anthocyanin compounds Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 244000037666 field crops Species 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229940005267 urate oxidase Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides a c & u & ox gene of c & lt/EN & gt and application thereof, which relate to pathogenicity and purine metabolism, belong to the technical field of microbial genetic engineering, and are derived from c & lt/EN & gt, wherein a cDNA sequence consisting of 906 nucleotides is shown as SEQ ID NO. 1; the protein coded by the CcUOX gene provided has an amino acid sequence consisting of 302 amino acids and shown in SEQ ID NO. 2; the CcUOX gene can be applied to the field of anthracnose resistance gene engineering of tea trees, and can be applied to the fields of food science and engineering; the engineering strain expressing the CcUOX gene can be used for degrading, utilizing and repairing the environment of caffeine waste, and can be applied to uric acid degradation; the CcUOX can be used as a gene target in the design and screening of the sterilizing bacteria of the colletotrichum camellia.
Description
Technical Field
The invention belongs to the technical field of microbial genetic engineering, and in particular relates to application of a camellia thorn spore fungus gene CcUOX in the fields of prevention and treatment of anthracnose of camellia plants, improvement of plant disease resistance and food safety.
Background
Colletotrichum fungi are asexual fungi belonging to the class of Coelomyces, melanomyces, melanomycetaceae, and their sexuality is ascomyceta, amanomycetaceae, amanomyces GlomerellaSpauld et Schrenck, and belongs to a class of plant pathogenic fungi distributed globally. The fungus has wide host range, and is parasitic from bare plant to angiosperm and from monocotyledonous plant to dicotyledonous plant. The pathogenic fungi of the genus, which often harm the roots, stems, leaves, flowers, fruits and seedlings of woods, fruit trees, vegetables, flowers, medicinal plants and field crops, can cause symptoms such as plant wilt, fruit rot, leaf spot and the like, and cause serious economic loss, are classified as eighth plant pathogenic fungi worldwide based on the importance of science and economy.
The tea contains abundant secondary metabolites such as tea polyphenol, theanine, alkaloids, glycosides, proanthocyanidins, anthocyanin compounds and the like, and the special quality of the tea is provided. Caffeine is one of the important purine bases of tea and is structurally characterized in that N at the 1,3 and 7 positions of xanthine is connected with 3 methyl groups. The content and distribution of caffeine in different varieties and different parts of different tea trees are different, and because the caffeine of the tea trees is mainly synthesized in chloroplasts, the caffeine is mainly distributed at the young shoot part of the tea trees, and the content is gradually reduced along with the maturity and aging of leaves. It has been demonstrated that caffeine may be related to plant disease resistance, with higher caffeine content being more resistant to disease.
Therefore, the research of the interaction of the biosynthesis of the caffeine and pathogenic bacteria of the tea tree is of great significance for revealing the disease-resistant mechanism of the tea tree.
Disclosure of Invention
The pathogenic gene for regulating and controlling the colletotrichum camellia (Colletotrichum camelliae) is derived from colletotrichum camellia, is named CcUOX, has a sequence shown as SEQ ID NO.1 and is a CcUOX gene open reading frame, and consists of 906 nucleotides, wherein the length of a coding region formed by the gene is 302 nucleotides; the amino acid sequence of the CcUOX protein coded by the CcUOX gene of the camellia sinensis is shown as SEQ ID NO: 2.
The deletion of the CcUOX gene causes the reduction of the pathogenicity of the camellia sinensis on host plants, the CcUOX gene and the protein coded by the CcUOX gene can be used as targets for the development of anti-camellia sinensis medicaments, and the compound capable of inhibiting the expression of the gene and the expression, modification and positioning of the protein of the CcUOX gene can be screened, so that the occurrence of the camellia sinensis can be effectively controlled and used as a novel bactericide.
Further, the host plant is one of plants of camellia, camellia oleifera, camellia japonica and the like.
The invention also aims to provide an application of the camellia thorn fungus CcUOX gene shown in SEQ ID No.1 or a protein coded by the camellia thorn fungus CcUOX gene and shown in SEQ ID No.2 as a control target in preparation of the camellia thorn fungus bactericide.
The invention also aims to provide a biocontrol microbial inoculum for preventing and controlling the campylobacter sakazakii, which contains a genetic engineering vector for blocking or inhibiting the expression of the campylobacter sakazakii CcUOX gene.
Further, the biocontrol microbial inoculum is one or more of A to C:
A. reduce the pathogenicity of the echinococcus camellia;
B. reducing the tolerance of the disc sporotrichum camellia to caffeine;
C. reducing degradation of uric acid.
Further, the plant is a host plant of the colletotrichum camellia.
Further, the biocontrol microbial inoculum contains a knockout vector of the c muox gene of the c muox camellia.
The invention also aims to provide a method for preventing and controlling the camellia thorn fungus, and the expression of the camellia thorn fungus CcUOX gene is blocked or inhibited by the knockout expression vector, so that the biocontrol strain with reduced pathogenicity is obtained.
The invention proves that the deletion of the CcUOX gene leads to the obvious reduction of the pathogenicity of the thorn fungus, the reduction of the tolerance to caffeine and the reduction of the uric acid metabolic capability. Therefore, the compound which can prevent the gene expression and the expression, modification and localization of the protein can be screened, and the occurrence of the colletotrichum camellia can be effectively controlled, thereby being beneficial to developing a novel bactericide. Namely, one important application of the CcUOX gene provided by the invention is that the expression of the gene and a protein product encoded by the gene can be used as important candidate target sites for designing and screening anti-camellia thorn disc spore medicaments.
It is still another object of the present invention to provide a recombinant protein, which is obtained by excessively inducing expression of the CcUOX gene by the over-expression vector, and is useful for reducing uric acid in high purine foods.
Further, the high-purine food is seafood, beer, animal viscera, beef and mutton, etc.
It is still another object of the present invention to provide a method for reducing purine bases in foods, which induces the expression of the c muox gene of c muox of camellia through the over-expression vector to obtain an expression protein for metabolizing uric acid in foods.
The invention also aims to provide a method for reducing purine base pollution in soil or water environment, and the expression of the CcUOX gene is promoted by the over-expression vector to obtain an over-expression strain with enhanced uric acid metabolic capability, which is used for repairing environmental treatments such as caffeine, uric acid and the like.
The cDNA sequence of the functional gene CcUOX which is derived from the fungus pathogenicity and the tolerance to caffeine of the colletotrichum camellia and can metabolize uric acid and consists of 906 nucleotides is shown as SEQ ID NO. 1; the protein coded by the CcUOX gene provided has an amino acid sequence consisting of 302 amino acids and shown in SEQ ID NO. 2; the CcUOX gene can be applied to the field of anthracnose resistance genetic engineering of tea trees; the CcUOX gene can be applied to the fields of food science and engineering; the engineering strain expressing the CcUOX gene can be used for degradation, utilization and environmental repair of caffeine waste; the engineering strain expressing the CcUOX gene can be applied to uric acid degradation; the CcUOX can be used as a gene target in the design and screening of the sterilizing bacteria of the colletotrichum camellia.
Drawings
FIG. 1 is a graph showing the prediction of amino acid function of a Cephalosporium camellia CcUOX; wherein the CcUOX gene is numbered CcaCcLH18_02012;
FIG. 2 is a schematic representation of the knockout strategy (gene replacement by homologous recombination) of the C.camellia sinensis CcUOX gene: wherein CCA is a wild type strain, pXEH is a knockout vector, and DeltaCcUOX is a CcUOX gene deletion mutant;
FIG. 3 shows PCR-validated electrophoretogram and qPCR expression profile of CcUOX gene deletion mutant:
wherein, the two primers are designed by using the nucleotide sequences at the downstream of the left arm and the upstream of the right arm in the diagram A, and the normal knockout homozygote replaces the target gene with the hygromycin gene through cross exchange and homologous recombination. Therefore, by PCR, one band conforming to the hygromycin band size can be amplified, namely the knockout homozygote. Panel B shows that wild-type cDNA has an expression level and knockouts ΔCcUOX-2, ΔCcUOX-44, ΔCcUOX-50 have no expression level using the CcUOX gene qPCR primer;
FIG. 4 is a pathogenicity comparison analysis of knockout mutant ΔCcUOX versus wild type strain C.camelliae and complement ΔCcUOX-C: wherein DeltaCcUOX is a knockout mutant, C.camelliae is wild type, deltaCcUOX-C-CcUOX is complement of a complement-supplementing tea tree anthracnose CcUOX gene, and a host is tea tree leaves;
FIG. 5 is a comparative analysis of the resistance of knockout mutant ΔCcUOX to 1mg/ml caffeine with wild type strain C.camelliae: wherein Δccoox is a knockout mutant and c.camelliae is wild type;
FIG. 6 is a comparative analysis of the tolerance of complement ΔCcUOX-C-CcUOX to 1mg/ml caffeine with wild type strain C.camelliae;
FIG. 7 is a comparative analysis of the degradability of wild type strain C.camelliae and mutants to 0.1% uric acid.
Detailed Description
In order to better describe the present invention, the following description will be given by way of specific examples, which are conventional methods unless otherwise indicated.
Correlation analysis of the CcUOX genes in example 1.
The CcUOX gene of tea tree anthracnose consists of 906 nucleotides and the encoded protein product consists of 302 amino acids. Blast alignment was found to encode urate oxidase as shown in figure 1.
The knockdown of the ccox gene of example 2 was genetically complementary.
1) Knock-out vector construction
Designing a primer by utilizing DNAMAN, synthesizing the primer by Shanghai biological technology limited company, and amplifying a fragment about 750bp upstream of a CcUOX gene by adopting the primers CcUOX-UP-F (5'-CGGAATTCTGAGATGAACCAACAGACC-3') and CcUOX-UP-R (5'-CGGGGTACCGTTGGCGGTTGTGGTTG-3') and taking genomic DNA of a tea tree anthracnose bacterial strain C.camelliae as a template; the primers CcUOX-DN-F (5'-CGGGATCCGTTGGGGCGCTGTTGAAA-3') and CcUOX-DN-R (5'-ACGCGTCGACAGAGGAAGAGAGCCGTGA-3') were used to amplify a fragment of about 900bp downstream of the CcUOX gene using genomic DNA of the tea plant anthracnose strain C.camelliae as template. Reaction system (25 μl): takara PrimerSTAR Max DNA Polymerase (2×) 12.5 μl; 1. Mu.L of each of the upstream and downstream primers (10. Mu.M); 1. Mu.L of template DNA; ddH 2 O9.5. Mu.L. Amplification procedure: (1) 98 ℃ for 10s; (2) 53℃for 15s; (3) 10s at 72℃the 1-3 steps were cycled 35 times. The PCR products were recovered and purified using a TAKARA gel recovery kit, and the upstream and downstream fragments were ligated with the pXEH vector using EcoRI+KpnI and BamHI+SalI, respectively, to construct a knockout vector (strategy shown in FIG. 2).
2) Transformation of tea tree anthracnose
a. Cultivation of Agrobacterium tumefaciens AGL-1
A single colony of the Agrobacterium tumefaciens strain AGL-1 containing the binary vector CcUOX is picked and inoculated into LB liquid medium containing 50 mu g/mL kanamycin and 25 mu g/mL rifampicin, and shake cultured for 36h to OD 600 =0.8 or so. Preparation of IM liquid Medium (100 mL:90mL ddH) 2 O;1mL of 50% glycerol; 1mL of 20% glucose; 4ml1M MES;2mL M-N buffer;1 mLTracell; 80 mu L K-buffer;250 μL of 20% NH N0;100 μL of 1% CaCl;1ml of 0.01% FeS0; 200. Mu.L 19.2% As), first at 90mL ddH 2 Adding medicines except FeS0 and As into O, mixing, taking 5ml of the shaken bacterial solution into a centrifuge tube with volume of 15ml, centrifuging for 5 minutes at 4000 turns, discarding the supernatant, adding 5ml of IM culture medium (without FeS0 and As), blowing once, centrifuging for 5 minutes at 4000 turns, discarding the supernatant, adding FeS0 and As into the IM culture medium, taking 5ml into a centrifuge tube with volume of 15ml, blowing once, transferring to an empty bottle, and shaking for 4 hours at 28 ℃. Culturing the rest of IM liquidThe base is placed in a refrigerator (newspaper package) at 4 ℃.
b. Spore-producing culture of tea tree anthracnose
Activating C.camelliae strain, inoculating the bacterial cake to PDB culture medium (20% of potato is boiled and filtered, 2% of glucose), shaking culturing at 28deg.C for 3-8 days, filtering supernatant with gauze, observing with microscope, and regulating spore concentration to 5×10 with hemocytometer 5 /mL。
c. Co-culture of agrobacterium tumefaciens and tea tree anthracnose conidium
Mixing the agrobacteria liquid induced in the IM liquid culture medium with the equal volume of anthrax spores with the adjusted concentration, taking 100 mu L of the agrobacteria liquid, coating the agrobacteria liquid on the IM solid culture medium with the glass paper, coating 6 plates, sealing the plates, and culturing for 2 days at the temperature of 28 ℃ in a dark place. After the co-cultivation, the cellophane was transferred to PDA medium containing 100. Mu.g/mL hygromycin and cultivation was continued under the same conditions. After 4-7 days, the expanded colonies were picked up and subjected to secondary screening on screening media containing the same antibiotics.
d. Verification of transformants
Transformants were screened by PCR amplification using hygromycin primers and the CcUOX gene primer. The amplification results were confirmed to be CcUOX gene deletion mutants in that hygromycin resistance gene inner primers HpTa (5'-GTCGTTTGACAAGATGGTTCA-3') and HpTb (5'-CGTCTGCTGCTCCATACAA-3') could be amplified to a 993bp fragment (as shown in FIG. 3A); two primers (5'-CGGTCCTTATCTCAATCCATC-3') were designed using the left arm downstream and right arm upstream nucleotide sequences (5'-GATGCGGGAAGAAAATGC-3'), and the normal knockout homozygote was a hygromycin gene replaced by a gene of interest by crossover exchange and homologous recombination. Therefore, by PCR, one band conforming to the hygromycin band size can be amplified, i.e., a knockout homozygote (as shown in FIG. 3B). At the same time, transcription was not smoothly performed at the RNA level due to deletion of the CcUOX gene, and expression was not detected using the QPCR primers (5'-TTCAGCAACCGAAACACC-3') and (5'-TGTAGACGAGGCAGACAACG-3') for the CcUOX gene. 3 independent CcUOX gene deletion mutants were selected from transformants: deltaCcUOX-2, deltaCcUOX-44, deltaCcUOX-50 were used for subsequent functional analysis.
Example 3, effect of the CcUOX gene on the pathogenicity of colletotrichum tea tree anthracnose.
Inoculating spore liquid: culturing each strain under the same culture condition for producing spore, collecting and concentrating spore liquid, diluting the spore liquid obtained by centrifugation to 1×10 with sterile water 6 Mixing the two parts per mL fully, sucking 20 mu L of spore liquid by using a liquid-transferring gun, dripping the spore liquid to two sides of the leaves of the host plant with the same batch size and good state, carrying out moisturizing culture on the inoculated host, observing the disease condition, and photographing and recording; inoculating a fungus cake: activating the strain on PDA, when the strain grows for 4d, using a puncher to punch out uniform bacterial cakes, reversely buckling the bacterial cakes on leaves of host plants, carrying out moisturizing culture on the inoculated hosts, observing the disease condition, and taking photos and recording. The difference in pathogenicity of wild type, knockdown and complement to host plants was investigated by means of spore fluid and bacterial cake combination, as shown in figure 4. The result shows that after the CcUOX is knocked out, the pathogenicity of the anthrax on a host plant is greatly reduced, and the pathogenicity of complement is basically the same as that of a wild type, which indicates that the CcUOX participates in regulating and controlling the pathogenicity process of the anthrax on the host plant and is an essential key gene for maintaining the virulence of the anthrax on the host plant.
Example 4, effect of the CcUOX gene on caffeine inhibition of colletotrichum tea.
The center of a PDA culture medium plate (diameter 5.5 cm) with pure PDA culture medium and caffeine concentration of 1mg/ml is respectively connected with a bacterial cake with the diameter of 0.6cm, and the bacterial cake is cultivated in darkness in a constant temperature incubator at 28 ℃ for 24 hours at intervals, and the colony diameter (unit: cm) is measured until hypha on a certain plate is fully paved on the whole plate.
Calculating inhibition rate
On PDA medium, the growth condition of the knockout mutant is basically consistent with that of the wild strain, and even the growth condition of the knockout mutant on PDA is better. However, after addition of 1mg/ml caffeine, the inhibition rate of the wild-type strain was 39.11% for 96 hours; the knockout mutant has obvious inhibition effect, the inhibition rate of 96h can reach 56.93%, and a significant difference exists between the knockout mutant and the wild type, as shown in figure 5.
After the original gene CcUOX was complemented/overexpressed with the CcUOX knockout mutant Δccuox, an enhancement of resistance to caffeine was shown in fig. 6.
Example 5 analysis of the effect of the ccuox gene on uric acid degradation.
After sterilization, spores of the C.Camelliae wild-type strain and the ΔCcUOX mutant strain were inoculated with 0.1% uric acid added to CM liquid medium, and shaking culture was performed for 48 hours, and the change in uric acid content was detected by hydrogen peroxide chromogenic reaction as shown in FIG. 7, ΔCcUOX-2 was pink, ΔCcUOX-44 was pink, and C.Camelliae wild-type was colorless. The strain of CcUOX over-expressed protein can be used for reducing uric acid in purine-rich foods such as seafood, beer, tea garden waste, coffee garden waste, tea grounds, coffee grounds, etc.
SEQ ID No. 1: ccUOX nucleotide sequence: 906bp
1ATGCCCGTTC TCGCCTCCGC CCGCTACGGC AAGGACAATG TCCGCGTCTA CAAGGTCGAG
61CGCCACGGCG ACTCCCAGAC CGTCACCGAG ATGACCGTCT GCTGCCTCCT CGAGGGCGAG
121ATCGAGACCT CCTACACCGT CGCCGACAAC AGCGTCGTCG TCGCCACCGA CTCCATCAAG
181 AACACAATCT ACATCAAGGC CAAGGAGAAC CCCATCAACC CGCCAGAGCT CTACGCCTCC
241ATCCTCGGCA CCCACTTCCT CGACACCTAC AAGCACATCC ACGCCGCCAA CATCAAGATC
301GTCCAGCACC GCTGGACCCG CATGACCGTC GACGGCAAGC CGCACCCGCA CTCCTTCTTC
361CGCGACGGCG AGGAGACCCG CAACGTCGAG GCCCGCATCT CCCGCAAGGA CGGCATCGCC
421CTCACCTCCA CCATCCAGAA GCTCACCGTC CTCAAGAGCA CCGGCTCCGC CTTCCACGGC
481TTCGTCCGCG ACGAGTACAC CACCCTGCCC GAGACCTGGG ACCGCATCCT CTCCACCGAC
541GTCGACGCCC AGTGGTCCTG GAAGTTCCCC GACGTCGCCG CCGTCAGGGC CGCCGTCCCC
601AAGTTCGACC CGGCCTGGCA GGCCGCCCGC GACATCACCA TGAAGACTTT CGCCGAGGAC
661GAGAGCGCCA GCGTGCAGAA CACAATGTAC AAGATGTGCG AGCAGATCCT CGCCGCCGTG
721CCAGAGGTCC TGACCGTCAC GTACACGCTC CCCAACAAGC ACTACTTTGA GATCGACCTC
781AGCTGGCACA ACGGCCTGAA GAACACGGGC AAAGACGCCG AGGTGTACGC GCCGCAGTCC
841GGCCCGAACG GTCTCATCAG GTGCGAGGTC GCGCGCTCTG CCAAGAACGA GACGGCCAAG
901TTGTAA
SEQ ID No. 2: amino acid sequence:
1MPVLASARYG KDNVRVYKVE RHGDSQTVTE MTVCCLLEGE IETSYTVADN SVVVATDSIK
61NTIYIKAKEN PINPPELYAS ILGTHFLDTY KHIHAANIKI VQHRWTRMTV DGKPHPHSFF
121RDGEETRNVE ARISRKDGIA LTSTIQKLTV LKSTGSAFHG FVRDEYTTLP ETWDRILSTD
181VDAQWSWKFP DVAAVRAAVP KFDPAWQAAR DITMKTFAED ESASVQNTMY KMCEQILAAV
241PEVLTVTYTL PNKHYFEIDL SWHNGLKNTG KDAEVYAPQS GPNGLIRCEV ARSAKNETAK
301 L*
the foregoing embodiment numbers of the present invention are merely for the purpose of description, and do not represent the advantages or disadvantages of the embodiments. From the description of the above embodiments, it will be apparent to those skilled in the art that the above example methods may be implemented by means of a superposition of some variants plus the necessary general techniques; of course, the method can also be realized by simplifying some important technical features. Based on such understanding, the technical solution of the present invention essentially or partly contributes to the prior art is: and the whole construction method is matched with the structures described in the various embodiments of the invention.
Finally, it should be noted that: the above embodiments are only for illustrating the technical solution of the present invention, and not for limiting the same; although the invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical scheme described in the foregoing embodiments can be modified or some or all of the technical features thereof can be replaced by equivalents; such modifications and substitutions do not depart from the spirit of the invention.
Claims (10)
1. A nucleotide sequence of the gene CcUOX of the colletotrichum camellia is shown as a sequence shown as SEQ ID NO.1, and the regulation of the gene CcUOX leads to pathogenicity of the colletotrichum camellia on host plants.
2. A protein encoded by the c muox gene of c muox as claimed in claim 1, wherein: the amino acid sequence of the protein is shown in SEQ ID NO: 2.
3. The CcUOX gene of claim 1 or the protein of claim 2, wherein: the regulation and control of the pathogenicity of the camellia sinensis is realized by improving the tolerance to caffeine.
4. A ccouox gene or/and protein as claimed in claim 3, wherein: the activity or/and the expression quantity of the gene or/and the coded protein of the gene of the campylobacter sphaeroides CcUOX in the campylobacter sphaeroides is increased to promote pathogenicity of pathogenic bacteria.
5. Use of the ccuoox gene according to claim 1 for the preparation of a medicament for controlling cercospora camellia, characterized in that: the medicament comprises an inhibitor of the CcUOX gene or an inhibition vector containing the CcUOX gene.
6. Use of the ccuoox gene of claim 1 to increase disease resistance in camellia plants.
7. The use according to claim 6, wherein: the use of the CcUOX gene mutant induces immunity in plants of the genus Camellia.
8. Use of a ccuoox gene according to claim 6 or a protein according to claim 2 for modulating resistance of a c.
9. The use of the ccuoox gene over-expressed protein of claim 1 in uric acid metabolism of a strain.
10. Use of the over-expressed protein according to claim 9 for reducing uric acid in a purine-rich food.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211457590.1A CN116676315A (en) | 2022-11-21 | 2022-11-21 | Cephalosporium camellia gene CcUOX and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211457590.1A CN116676315A (en) | 2022-11-21 | 2022-11-21 | Cephalosporium camellia gene CcUOX and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116676315A true CN116676315A (en) | 2023-09-01 |
Family
ID=87787856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211457590.1A Pending CN116676315A (en) | 2022-11-21 | 2022-11-21 | Cephalosporium camellia gene CcUOX and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116676315A (en) |
-
2022
- 2022-11-21 CN CN202211457590.1A patent/CN116676315A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109777810B (en) | Application of PUB41 gene as negative regulatory factor in improving resistance to tomato gray mold and bacterial wilt | |
CN110669773B (en) | Application of gene FoPDCD5 in regulation and control of pathogenicity of banana fusarium oxysporum | |
CN105154454B (en) | Pathogenicity-related botrytis cinerea gene BcArs2 and application thereof | |
CN109609526B (en) | Barley stripe disease pathogenic gene PgPBS and application thereof | |
CN101418040B (en) | Plant jasmonate acid signal transduction regulatory protein and coding gene and use thereof | |
CN110358776B (en) | Rhizoctonia solani pathogenic related gene and application thereof | |
CN114317570A (en) | Gene RcAOS for encoding Chinese rose allene oxide synthase and application of gene RcAOS in resisting Chinese rose gray mold | |
CN117660478A (en) | Gene for improving resistance of potatoes to late blight and application thereof | |
CN105624186A (en) | Oryza sativa autophagy-related protein OsATG8b (oryza sativa autophagy-related gene 8b) and novel application of gene of oryza sativa autophagy-related protein OsATG8b | |
CN116425843A (en) | Phytophthora capsici growth and development regulation protein PcAGO1, and coding gene and application thereof | |
CN116676315A (en) | Cephalosporium camellia gene CcUOX and application thereof | |
CN102140446A (en) | Application of rape iMyAP gene over-expression in sclerotinia sclerotiorum resistance of rape | |
CN102942621B (en) | Plant powdery mildew resistance related protein TaCAF1 and its coding gene and application | |
CN104878027A (en) | Juglans sigillata Dode ribonuclease gene JsRNase and application thereof | |
CN114854775B (en) | Application of BcSfp1 gene in plant gray mold control and disease resistance improvement | |
CN114854770A (en) | Application of BcSpd1 gene in preventing and treating plant gray mold and improving disease resistance | |
CN113621626B (en) | Application of FoCcw14 gene in regulation and control of endophytic fungi-rice symbiotic system to rice blast resistance | |
CN113684199B (en) | Rice cysteine protease coding gene OsRD21 and application thereof in rice blast resistance | |
CN116375835B (en) | Application of Yan flower MYB4b protein in regulation and control of plant leaf morphology | |
CN115215931B (en) | Use of protein IbC H18 related to vine cutting disease and soft rot disease or substance for regulating and controlling expression of protein IbC H18 | |
CN109666680B (en) | Strain delta Aflsnt2 not producing aflatoxin and application thereof in preventing and treating aflatoxin pollution | |
CN106905422B (en) | Pathogenic gene and protein of verticillium dahliae and application thereof | |
JP2007306917A (en) | Method for increasing the resistance of rice plant to pathogenic microorganism and pathogenic microorganism-resistant rice transformant | |
CN118028315A (en) | Gene FveAFB for regulating and controlling herbicide resistance of strawberries, encoding protein and application thereof | |
CN117304285A (en) | Fusarium pseudograminearum FpMCoL protein, and coding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |